G. Bodem

631 total citations
47 papers, 463 citations indexed

About

G. Bodem is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, G. Bodem has authored 47 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in G. Bodem's work include Cardiac electrophysiology and arrhythmias (10 papers), Analytical Methods in Pharmaceuticals (6 papers) and Poisoning and overdose treatments (5 papers). G. Bodem is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Analytical Methods in Pharmaceuticals (6 papers) and Poisoning and overdose treatments (5 papers). G. Bodem collaborates with scholars based in Germany and United States. G. Bodem's co-authors include Hermann R. Ochs, David J. Greenblatt, R Gugler, H. J. Dengler, Thomas W. Smith, Jerold S. Harmatz, Michel Eichelbaum, Richard I. Shader, Marcia D. Allen and Eberhard Grube and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

G. Bodem

45 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Bodem Germany	13	139	95	79	74	63	47	463
Yin‐Gail Yee United States	12	217 1.6×	77 0.8×	73 0.9×	64 0.9×	76 1.2×	16	510
E von Möllendorff United States	9	168 1.2×	59 0.6×	43 0.5×	88 1.2×	37 0.6×	12	430
K. OʼMalley Ireland	9	167 1.2×	54 0.6×	96 1.2×	107 1.4×	44 0.7×	16	562
R. E. Vestal United States	8	151 1.1×	70 0.7×	129 1.6×	146 2.0×	56 0.9×	12	607
David A Willard United States	11	190 1.4×	176 1.9×	62 0.8×	58 0.8×	50 0.8×	14	569
Sampat M. Singhvi Malaysia	8	191 1.4×	187 2.0×	60 0.8×	58 0.8×	55 0.9×	12	544
Margaretha Groschinsky‐Grind Sweden	11	176 1.3×	80 0.8×	94 1.2×	98 1.3×	99 1.6×	14	593
T E Gaffney United States	14	203 1.5×	125 1.3×	73 0.9×	70 0.9×	28 0.4×	32	722
Richard P. Koshakji United States	14	145 1.0×	89 0.9×	79 1.0×	145 2.0×	23 0.4×	22	594
Klaus D. Raemsch Germany	6	90 0.6×	61 0.6×	54 0.7×	49 0.7×	33 0.5×	8	376

Countries citing papers authored by G. Bodem

Since Specialization

Citations

This map shows the geographic impact of G. Bodem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Bodem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Bodem more than expected).

Fields of papers citing papers by G. Bodem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Bodem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Bodem. The network helps show where G. Bodem may publish in the future.

Co-authorship network of co-authors of G. Bodem

This figure shows the co-authorship network connecting the top 25 collaborators of G. Bodem. A scholar is included among the top collaborators of G. Bodem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Bodem. G. Bodem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ochs, Hermann R., David J. Greenblatt, G. Bodem, & H. J. Dengler. (1982). Disease-related Alterations in Cardiac Glycoside Disposition. Clinical Pharmacokinetics. 7(5). 434–451. 9 indexed citations

Ochs, Hermann R., David J. Greenblatt, Jerold S. Harmatz, G. Bodem, & H. J. Dengler. (1981). Clinical implications of serum digoxin concentrations. Journal of Molecular Medicine. 59(10). 501–507. 11 indexed citations

Ochs, Hermann R., G. Bodem, & David J. Greenblatt. (1981). Effect of dose on bioavailability of oral digoxin. European Journal of Clinical Pharmacology. 19(1). 53–55. 9 indexed citations

Ochs, Hermann R., David J. Greenblatt, Jerold S. Harmatz, G. Bodem, & H. J. Dengler. (1981). Clinical implications of serum digoxin concentrations. The American Journal of Cardiology. 47. 486–486. 1 indexed citations

Ochs, Hermann R., G. Bodem, & David J. Greenblatt. (1981). Impairment of Digoxin Clearance by Coadministration of Quinidine. The Journal of Clinical Pharmacology. 21(10). 396–400. 20 indexed citations

Gugler, R, et al.. (1980). Comparative pharmacodynamics and plasma levels of beta‐adrenoceptor blocking drugs.. British Journal of Clinical Pharmacology. 10(4). 337–343. 21 indexed citations

Bodem, G., et al.. (1979). [Prospective evaluation of glycoside therapy of patients on admission to hospital (author's transl)].. PubMed. 68(1). 41–9. 4 indexed citations

Bodem, G., et al.. (1979). Enhanced Transformation of Digitoxin to Dihydrodigitoxin in Humans with Renal Failure. The Journal of Clinical Pharmacology. 19(4). 195–199. 6 indexed citations

Bodem, G., et al.. (1978). Digitaliswirkung auf die Extremit�tendurchblutung des Menschen. Journal of Molecular Medicine. 56(10). 515–519. 3 indexed citations

10.

Bodem, G., et al.. (1978). [Digitoxin metabolism in patients with kidney insufficiency].. PubMed. 83. 1656–9. 3 indexed citations

11.

Ochs, Hermann R., David J. Greenblatt, G. Bodem, & Jerold S. Harmatz. (1978). Dose-independent pharmacokinetics of digoxin in humans. American Heart Journal. 96(4). 507–511. 26 indexed citations

12.

Bodem, G., et al.. (1977). [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 107(19). 658–66. 1 indexed citations

13.

Gugler, R, et al.. (1976). [Plasma level of pindolol (Visken) under long-term treatment, computed from pharmacokinetics after a single dose].. PubMed. 82 Pt 2. 1689–91. 1 indexed citations

14.

Bodem, G.. (1976). [Radioimmunological estimation of cardiac glycoside concentration in the plasma].. PubMed. 11(2). 97–100. 1 indexed citations

15.

Gugler, R, G. Bodem, & H. J. Dengler. (1976). Pharmacokinetics of β-Receptor-Blocking Agents in Relation to Their Anti-Hypertensive Effect. Clinical Science. 51(s3). 473s–475s. 3 indexed citations

16.

Bodem, G., et al.. (1976). [Digitalis therapy in arterial occlusive diseases].. PubMed. 82 Pt 2. 1943–6. 1 indexed citations

17.

Ochs, Hermann R., et al.. (1975). Absorption of digoxin from the distal parts of the intestine in man. European Journal of Clinical Pharmacology. 9(2-3). 95–97. 25 indexed citations

18.

Bodem, G., et al.. (1974). Pharmacokinetics of practolol in renal failure. European Journal of Clinical Pharmacology. 7(4). 249–252. 16 indexed citations

19.

Bodem, G., et al.. (1973). [Pharmacokinetic studies on H3-digoxin and H3-lanatosid in man].. PubMed. 23(1). 64–74. 23 indexed citations

20.

Gugler, R, et al.. (1973). [Influence of thyroid function on human drug metabolism].. PubMed. 79. 1230–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact